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Promotion of Gastrointestinal Tract
Tumors in Animals: Dietary Factors
by Paul M. Newberne* and Thomas Schrager*
The biological mode of action of tumor promoters, exemplified by the phorbol esters, is a subject
of intensive study in a number of laboratories. A few investigators have recently begun to examine
the role of dietary nutrients in tumor promotion, but the available data are sparse and interpreta-
tion difficult. A few examples are provided to indicate that some nutrients may be important in the
promotion of cancer. However, the fine dividing line between effects on initiation or on promotion,
so clearly shown in the mouse two-stage skin cancer model, is not so clear as yet in models used for
studies in nutritional carcinogenesis. The animal models for these studies have been primarily rats,
mice and hamsters. These have shown that nutrients which appear to have promotion activity are
zinc deficiency and 13-cis-retinoic acid for the esophagus; vitamin A deficiency and lipotrope defi-
ciency for the forestomach, unsaturated fat and vitamin A deficiency for liver and colon, lipotrope
deficiency for the liver; selenium for the liver. It is probably more correct at this early stage of in-
vestigation to consider the effects of nutrients acting either during the time of exposure to the car-
cinogen, or, after such exposure and when no detectible carcinogen is found in the animals tissues,
rather than as promoters in the strict sense.
Introduction
It is becoming increasingly clear that the carcino-
genic process in both humans and experimental ani-
mals is probably a multistep process which occurs
over long periods of time. Furthermore, many fac-
tors' appear to interact in the evolution of a malig-
nant tumor from an initiated cell. When a group of
normal cells is exposed to a carcinogen, neoplasia
does not happen immediately. There is a lag time,
ranging from months in animals to decades in hu-
mans. Following initiation by a carcinogen, a step-
wise change in properties of the cell occurs to in-
clude hyperplasia, metaplasia, benign neoplasia and
'finally malignant neoplasia. It is the malignant tu-
mor that is of greatest significance to the host, be-
cause benign tumors can be excised and rarely if
ever create a problem, aside from mechanical inter-
ference with normal function of the organ in which
it is located.
It is essential that we understand factors and
events taking place during the transition of normal
to malignant cells if means for interrupting these
changes are to be identified. In some cases the early
stages of tumor formation are reversible and fur-
thermore some tumors do in fact regress; in the
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later stages of tumorigenesis the process is less
easily reversed.
The concept of at least two stages in the develop-
ment of a tumor (initiation and promotion) has been
generally accepted by oncologists. Thus attempts
have been made to identify initiating agents and
promoting agents and to further define their modes
of action (1-6).
A major advance in knowledge about tumor pro-
motion was the isolation and identification of the
phorbol esters which are active principles of croton
oil, the most classical tumor promoter. Since the
phorbol esters have been identified and made avail-
able for experimentation, they have been the sub-
ject of intensive study in a number of laboratories,
relative to the biochemical and biological effects of
these chemicals and related materials. However, not
all of the biological effects are necessarily those as-
sociated with tumor promotion, but they may aid in
the elucidation of the mode of action of tumor pro-
moters and are usually discussed within the same
context as promoters. The term, tumor promoter, is
often used interchangeably with cocarcinogen, syn-
ergist, or accelerating and enhancing agent. There
is, however, a distinction in the method of biological
testing for tumor promoters and for cocarcinogens.
The majority of studies involving initiation and
promotion have been done by using the mouse skinNEWBERNEAND SCHRAGER
model for two-stage carcinogenesis which involves
an initiating agent and a promoting agent. By defini-
tion, an initiating agent is an agent which results in
benign and malignant tumors when applied on
mouse skin in a single dose, followed by repeated
applications of a promoting agent. When the initi-
ating agent is given alone it does not result in the
induction of tumors because of the dose that is used.
However many of the agents that are used as initi-
ators in two-stage carcinogenesis, such as the aro-
matic hydrocarbons, benzo(a)pyrene and 7-12-di-
methylbenzanthracene, are carcinogenic. Further-
more, some noncarcinogenic initiating agents for
mouse skin are also known, as shown in Table 1. In
addition, not all chemical carcinogens are initiating
agents. They are usually carcinogens which have to
be activated in vivo to become the carcinogenic in-
termediates.
The definition of a promoting agent may differ
from one investigator to another, but in general it is
an agent which, when applied repeatedly after a sin-
gle dose of an initiating agent, results in benign and
malignant tumors. Furthermore, all known promo-
ting agents have in addition weak tumorigenic ac-
tivity. Initiators and promoters are mechanistically
and temporally interrelated and cannot be sepa-
rated. If the sequence of applications is reversed,
few if any tumors appear. While the phorbol esters
and their derivatives are best known and the most
widely studied promoters there are others that are
of historical interest including (7), anthranalin (8)
and dodecane.
The above definitions of initiator and promoter
are for operational use only but serve a purpose in
the context of this presentation. There are many
others which are. much more exhaustive and per-
haps even more accurate (9).
An additional definition that may be useful is that
of a cocarcinogen. In studies dealing with cocarcino-
genesis, two agents are administered simulta-
Table 1. Initiating agents which are not carcinogenic
on mouse skin.a
Compound
Dibenz(a,c)anthracene
Chryseneb
Benz(a)anthraceneb
Urethane"
Triethylenemelamine
1,4-Dimethanesulfonoxy-2-butyne
Epichlorohydrind
Chloromethyl methyl etherd
aData of VanDuuren (6).
bThese are considered borderline carcinogens by some.
cCauses lung tumors in mice, lymphoma in rats.
dInduces sarcomas in mice by subcutaneous injection.
neously, usually in repeated applications or expo-
sures, and the combination of the two results in
higher tumor incidences than either agent alone.
For this reason, there is an operational difference
and probably a real difference in mode of action be-
tween cocarcinogens and tumor promoters since not
all cocarcinogens are tumor promoters nor are all
tumor promoters cocarcinogens (6). Table 2 com-
pares the activities of tumor-promoting and cocarci-
nogenic agents.
Table 3 lists the characteristics of stages of initia-
tion and promotion in skin carcinogenesis as eluci-
dated by Pitot (9). This is not to imply, however,
that these same characteristics may apply to carci-
nogenesis in other organs and tissues.
Environmental agents including diet and nutri-
tion can modulate the effects of promoting agents.
As early as 1944, Tannenbaum demonstrated an ef-
fect of nutritional tumor promotion (10). Later,
others showed effects on tumor promotion by nutri-
tional factors by varying the quality and quantity of
Table 2. Comparison of tumor-promoting and
cocarcinogenic activities.a
Tumor-promoting Cocarcinogenic
Compound activity activity
Phorbol myristate acetate + +
Anthralin + +
n-Dodecane + +
Linalyl oleate - +
Phenol +
Catechol - +
Resorcinol -
Hydroquinone -
Eugenol -
Pyrogallol - +
Pyrene - +
Fluoranthene - +
Benzo(e)pyrene ? +
aData of VanDuuren (6).
Table 3. Characteristics of stages of initiation and promotion
in skin carcinogenesis.a
Initiation Promotion
Irreversible, with "memory" Reversible, at least in early
stages
Initiated cells and immediate
progeny not usually identi-
fiable
"Pure" initiation (incomplete
carcinogen) causes irrevers-
ible change but no neo-
plasm unless promoter
applied
Dependent on cell cycle and,
for many chemicals, on the
metabolism of the cell
aData of Pitot (9).
Promoted neoplasm seen
grossly
Promoting agents not
carcinogenic but may pro-
mote fortuitously initiated
cells (i.e., background)
Modulated by diet, hormonal,
environmental and related
factors
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nutritional components fed to the animals during
carcinogenesis (11-13). Sporn (14) and others have
shown that several types of neoplasms can be pre-
vented by the use ofretinoids.
In regard to promoters it should be pointed out
that initiating agents are mutagenic because they
bind covalently to DNA. Phorbol ester, for example,
a promoting agent does not bind covalently to DNA
and is not mutagenic. However, continued long-term
painting of phorbol ester on mouse skin may result
in a small number of tumors. These observations
point out the reason that the Ames assay or other
conventional mutagenesis assays will not pick up
promoters, and further there is no evidence to date
that this class of promoters requires metabolic acti-
vation. This is in contrast to most of the initiating
agents.
Nutrients and Nutrient Deficits as
Promoters of the Carcinogenesis
Process
At this point it is not clear as to whether or not
nutrients per se or deficiencies of nutrients are act-
ing as promoters or are acting in concert with other
factors to enhance or inhibit carcinogenesis. Except
for mammary carcinogenesis, where there does
seem to be some evidence for tumor promotion,
there is little in the literature clearly defining the
time at which nutritional deficits or excess exert
their effects. For that reason it is not possible to
state clearly that we are dealing with a promotional
activity in those nutrients that do, in fact, affect the
incidence of induced cases-it is possible to define
the effects of a nutrient only as they relate to
whether they are operating during the time the car-
cinogen is administered or following the administra-
tion of the carcinogen and during the growth stage
of tumorigenesis. A part of the problem is the need
for repeated application or doses of the carcinogens
used in most nutrition studies. Most of the data pre-
sented in this paper will attempt to relate the nu-
trient effects to time: whether during treatment,
following treatment, or both. Thus we will not be
dealing with the subject of promoters in the strict
sense of the definition.
In so far as the gastrointestinal tract is con-
cerned, we will include the liver, although it is being
covered in more detail in other presentations at this
conference. In addition, we will consider the esopha-
gus, the stomach, the pancreas and the colon.
Esophageal Carcinogenesis
Esophageal cancer offers a unique epidemiologic
model for the study of cancer causation and a means
to learn more about initiation or promotion of this
unique neoplasm. The 300-fold worldwide variation
of this type of tumor provides the opportunity to
identify environmental factors associated to in-
creased risk to test these factors in appropriate ani-
mal models (15).
Epidemiologic studies have already shown that in
areas of low and moderate incidence of the disease,
such as the United States and Western Europe, the
consumption of high levels of alcohol correlate
strongly to increased risk (16). Mossbach and Vidde-
back (17) have reported that 65% of 84 male esopha-
geal cancer patients were alcoholics, and 21% of
them were employed as brewery workers. In other
studies it has been shown that the risk of the dis-
ease is 17 times greater for alcoholics than nonalco-
holics (18). In France and in some parts of Africa,
esophageal cancer appears to correlate to the type
of alcoholic beverage more than to the amount that
is consumed, suggesting some type of contaminant.
In many high incidence areas of the world, such
as Iran, parts of Russia, the Transkei of South Af-
rica and parts of China, there is little if any alcohol
consumption; other factors must be sought as etio-
logic agents (19). In a large study in South African
esophageal cancer areas, van Rensburg (20) ob-
served that those at high risk consumed dietary sta-
ples which result in deficiencies of riboflavin, nico-
tinic acid, magnesium and zinc. Our own studies
have shown that Chinese patients with esophageal
cancer in the Hong Kong area have reduced levels
of zinc in hair, serum and esophageal tissue, com-
pared to healthy controls or patients with other
types of cancer (21). Table 4 indicates the observa-
tions in human esophageal cancer patients.
We have followed up on the observations in hu-
man esophageal cancer patients using animal mod-
els and observed a number of enhancing and prob-
ably promoting effects of zinc deficiency (22). A se-
ries of studies in rats has clearly shown that zinc de-
ficiency lowers serum, hair and esophageal concen-
trations of zinc and significantly enhances induction
of esophageal tumors by methylbenzylnitrosamine.
Furthermore, the results of recent studies (Table 5)
have revealed significant effects of zinc deficiency
and alcohol as well as zinc deficiency combined with
ethyl alcohol and 13-cis-retinoic acid (24). 13-cis-
retinoic acid combined with alcohol further en-
hances the effect of zinc deficiency.
Table 6 illustrates clearly the remarkably en-
hancing effect of zinc deficiency alone but also
shows that putting rats back on a control diet after
exposure to the carcinogen during zinc deficiency
significantly reduced the tumor incidence. This im-
plies that the promotion stage or growth stage of
the tumor is affected by zinc deficiency but does not
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rule out an effect during the initiation period. These
data indicate that zinc deficiency is acting during
exposure to the carcinogen (initiation) as well as af-
ter the exposure (promotion). The observation of the
apparent enhancing effect of 13-cs-retinoic acid on
esophageal cancer is directly opposed to the usual
observation with the retinoids wherein it is benefi-
cial and inhibitory (25). While this observation of an
effect on esophageal tumors was not expected, nei-
ther is it totally surprising. In other studies using
the hamster lung cancer model we found that hy-
pervitaminosis A actually enhanced respiratory
Table 4. Zinc and copper levels in serum and hair of normal
humans and those with various disorders.a
Znb Cub
Serum, g0g%
Normal subjects 102.7 ± 18.5(15) 133.4 + 30.5(15)
Patients with 78.0 ± 14.9(20) 159.4 ± 44.4(20)
esophageal cancer
Patients with other 114.4 ± 31.8(6) 148.6 ± 102.(6)
types of cancer
Patients with other 96.2 ± 15.0(9) 146.7 ± 39.4(9)
disorders
Hair, ppm
Normal subjects 195.0 ± 29.0(16)
Patients with 162.0 ± 33.0(19)
esophageal cancer
Patients with other 169.0 ± 37.0(4)
types of cancer
Patients with other 212.0 ± 48.0(8)
disorders
aData of Lin et al. (21).
bNumbers in parentheses are number of subjects.
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tract tumor formation (26). In this case the excess
vitamin A appeared to be enhancing the tumor for-
mation during the promotional stage, since the
higher concentrations of vitamin A were adminis-
tered beginning one week after the last dose of car-
cinogen (Fig. 1).
Table 5. Effect of zinc deficiency, alcohol and 13-cis-retinoic
acid on esophageal tumors in rats.a
Tumor induction
Treatment No. %
Control diet 0.0 0.0
Control diet + MBN 14/35 40.0
Zinc-deficient diet + MBN 30/34 88.0
Zinc-deficient diet during MBN dosing, then 18/35 51.4
control diet
Zinc-deficient diet + MBN + alcohol 25/30 80.3
Zinc-deficient diet + MBN + alcohol + 34/35 97.1
13-cis-retinoic acid
aData of Schrager and Newberne, (23).
Table 6. Promoting effect of zinc deficiency on esophageal
tumors in rats induced by methylbenzyl nitrosamine (MBN).a
Tumor-
bearing
rats No. tumors
Treatment No. % Single Multiple
Control + MBN 5/34 15 3 2
Zn-deficient + MBN 30/34 88 4 26
Control during exposure, then 21/34 62 9 12
Zn-deficient
aRats were given 2.5 mg/kg MBN twice weekly for 3 weeks,
total 15 mg/kg body weight.
25 30 35 40 45 50 55 60 65 70
LAST BENZO (a) PYRENE INSTILLATION
75 80 85
FIGURE 1. Probability of respiratory tract tumors in hamsters given an intratracheal dose of benzo(a)pyrene (BP). The vitamin A
was given beginning 1 week after the final BP dose, illustrating a promoting effect.
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Gastric Cancer
Gastric cancer was one of the most common neo-
plastic diseases in the United State at the turn of
the century, but the morbidity and mortality from
this type neoplasm have decreased steadily in the
intervening years. However, in other parts of the
world, particularly in the mountain regions of cen-
tral and western Latin America, northern and east-
ern Europe, Iceland, and in some parts of Japan,
gastric cancer remains one of the more common
types of neoplasms. A decreased incidence has re-
cently been observed in some of these areas (27-29).
Etiologic agents for gastric cancer in human pop-
ulations are not known, but a number of foods and
environmental contaminants have been suggested
(30, 31).
Migrant studies have suggested that chronic in-
take of selected dietary factors is associated with
high risk for gastric cancer. For example the intake
of dried and salted fish or pickled or smoked fish,
prevalent in many countries particularly Japan,
seem to be important. Local customs and availabil-
ity of food which sometimes results in decreased in-
take of fresh fruits and vegetables also seem to be
involved. Nitrate, nitrite and nitrosamines have
been associated by some with the incidence of gas-
tric tumors in some geographic areas. However, de-
spite all of the epidemiologic and control laboratory
experimental work that has been done the causa-
tive agent(s) in human gastric cancer remain elusive.
With the advent of an animal model for glandular
gastric cancer, numerous investigations have been
conducted. The discovery that nitrosourea com-
pounds would produce antecedent lesions as well as
gastric cancer has considerably advanced the efforts
toward revealing the cause(s) of gastric carcinoma.
A number of individuals have shown that an aston-
ishing number of substrates, including dietary
amines, can be nitrosated to carcinogenic nitrosa-
mines and nitrosamides in the stomach (32-34).
Weisburger et al. (35) have produced some inter-
esting results with nitrate, nitrite and food extracts,
particularly those from fish, which clearly support
the results of others. These studies point out (Table
7) that substances in fish and other meat products
in particular will combine with nitrite and when fed
to rats result in alterations in gastric epithelium
suggestive of neoplastic changes.
Vitamin C and Stomach Cancer
The question of whether or not vitamin C (ascor-
bic acid) has an effect on cancer of the stomach is
controversial. It has been shown to protect against
cancer (36), to have no effect (37), and to possibly en-
hance carcinogenesis (38). There are, however, data
which, when put in perspective, seem to indicate
that moderate doses of ascorbic acid offer some pro-
tection against experimental gastric cancer associ-
ated with carcinogens or procarcinogens in foods.
Human epidemiologic data also indicate that ascor-
bic acid is negatively associated with the develop-
ment of gastric cancer (39-41).
There is no convincing evidence that vitamin C is
useful as a therapeutic agent in cancer patients
even though there is a great deal of enthusiasm for
such treatment (42-46).
We have observed in our laboratory (26) that tu-
mors of the forestomach were inhibited by high lev-
els of vitamin A (retinyl acetate, RA). Hamsters
given carcinogenic doses of benz(a)pyrene and then
treated with either 1600 or 2400 Mg of retinol per
week had a significantly decreased number of tu-
mors (Table 8). Since the vitamin A was acting dur-
ing the post exposure period it was effective on the
Table 7. Incidence of stomach epithelium hyperplasia and intestinal metaplasia.a
Group Effective Forestomach Glandular stomach
and no. of squamous cell Glandular Intestinal
treatment rats hyperplasia hyperplasia metaplasia
I Fish extract alone 8 0 1 1
II Fish extract + NaNO2 12 5 6 6
a Data of Weisburger et al. (35).
Table 8. Incidence of forestomach papillomas induced by BP in hamsters and effects of retinyl acetate (RA).
No. of papil-
RA dose, No. of % with lomas/papilloma-
Mg wk hamsters papilloma bearing hamstera
100 109 50 2.9± 0.2
1600 111 25b 2.2± 0.3
2400 102 26b 3.1 ± 0.2
a Means ± S.E.
b Compared to hamsters given 100 Mg RA/week, p<O.005.
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promotional stage of tumor development, much like
the effect of retinoids on the mouse two-stage skin
model.
While the incidence of gastric cancer has steadily
decreased in the United States over the past de-
cades, nothing factual is known about the reasons
for the decline. It has been proposed that the de-
crease is because of better distribution of food with
adequate fresh food sources of vitamins C and E.
Furthermore, there has been an increase in the use
of antioxidants in foods of natural or synthetic ori-
gin; this may have had some effect on the decline
but other suggestions are equally viable. For exam-
ple, another suggestion has been that foods are now
refrigerated; the improvement in preserving of
foods during the past three or four decades is be-
lieved to contribute to the decrease in gastric carci-
noma during this period. This however conflicts
with the observations of Wynder et al. (47) that gas-
tric cancer exhibits a north-south gradient (or south-
north gradient in the Southern Hemisphere) with
greater incidence in the more temperate or frigid
zones.
Liver Carcinogenesis
The current literature includes many papers sup-
porting the development of cancer of the liver
through a multistep process involving initiation and
promotion (48-49). However, despite the large num-
bers of reports and the clear indications that liver
carcinogenesis is a complex multistage process,
very little is known about the influence of diet on
such processes. Reports in the literature use the
terms initiation and promotion in a rather loose
manner.
Our laboratory has done much of the work on the
effects of lipotrope deficiency on hepatocarcinogene-
sis (50-54). While it has been clearly shown that lipo-
trope deficiency profoundly affects the rate and inci-
dence of liver tumors, the time during which its ef-
fect is exerted has not been clearly defined. A few
examples are given below to illustrate the effects of
lipotrope deficiency on the enhancement of hepato-
cellular carcinogenesis, some of which indicate an ef-
fect during both initiation and promotion stages.
Table 9 lists a few of the experiments with various
types of carcinogens showing the effects of a low
lipotrope diet on the development of tumors. Clear-
ly, except for one carcinogen (dimethylnitrosamine,
DMN), there is an enhancing effect of the diet on tu-
morigenesis. Since these were fed or administered
during and after the carcinogen we are unable at
this point to determine whether or not the effect
was during initiation or promotion or both. It ap-
pears that a part of the effect of the lipotrope defi-
cient diet on hepatocarcinogenesis is exerted (55)
through its influence on microsomal enzyme activity
(Table 10) and on aflatoxin metabolism (Table 11).
Table 12 presents data that indicate the dietary
effects of quality and quantity of two types of fat on
aflatoxin carcinogenesis. From these data it would
appear that beef fat exerted just as much effect in
the promotional or growth stage of the tumors as in
Table 9. Hepatocarcinogenesis in rats fed diets deprived of lipotropes.a
Tumor incidence, %
Treatment Control Lipotrope-deficient
AFB,, 375,ug (total 3 experiments) 6-15 22-87
Diethylnitrosamine, 40 mg/kg, 18 weeks 70 88
Dibutylnitrosamine, 3.8 mg/kg total 24 64
Dimethylnitrosamine
100 mg/kg in diet, 3 weeks 28 27
25-50 mg/kg in diet, 8 weeks 74 50
Acetylaminofluorene, 0.0125% in diet, 16 weeks 2 experiments 19-61 41-91
DDCP, 195 mg total 29 63
a Data of Rogers and Newberne (54).
Table 10. Dietary effects on AFB, metabolism.a
Control Lipotrope-deficient
AFB, metabolism
AFB1 45.6 ± 3.8 43.5 ± 4.1
Aflatoxin Q, 0.76 ± 0.04 0.84 ± 0.34
Aflatoxin M, 0.72 ± 0.04 0.88 + 0.12
MFO type 1 spectra
AAmaxo mmole/mg protein 10.3 ± 0.8 7.6 ± 0.9
KS, mM 0.27 ± 0.04 0.38 + 0.10
a Data of Campbell et al. (55).
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promotion and initiation stages combined. This was
not the case with corn oil, since with corn oil only,
after the carcinogen has been given, there was sig-
nificantly less effect than when it was given during
and after carcinogen exposure (initiation and promo-
tion stages).
Another most interesting promoting effect has
recently been revealed in our laboratory with the
BOC3F1 mouse which has a high incidence of sponta-
neous liver tumors (57). Table 13 shows that a sim-
ple partial hepatectomy significantly enhances the
tumor incidence to 40% compared to zero in the
control. Choline deficiency has an even more pro-
found effect raising the level to 100%. Interestingly,
the deficient diet plus a partial hepatectomy ap-
peared to be less tumor enhancing than the choline
deficiency alone. This observation will be reported
in more detail in another publication.
Pancreatic Cancer
Carcinoma of the pancreas is a common, highly
lethal gastrointestinal type of malignancy. The inci-
dence appears to be rising in United States popula-
tions and now is second only to cancer of the colon
as a cause of death from gastrointestinal neoplasms.
Each year from 20,000 to 25,000 new cases are diag-
nosed in the United States, and 95% of these are
expected to die from the disease. As with other
types of cancer, particularly esophagus, excessive
alcohol, smoking, and exposure to industrial com-
pounds including benzidine, urea, and methylnitro-
samine appear to play a prominent role in cancer of
the pancreas. However, proof of a cause-effect rela-
tionship has not been firmly established.
A number of epidemiologic studies, including the
recent controversial report by McMahon, has
served to increase the interest in pancreatic carci-
noma (58, 59). While the epidemiologic data are not
firm, experimental results from studies conducted
in experimental animals are convincing. The induc-
tion of pancreatic cancer in rats by the injection of
azaserine was first recorded in 1975 (60). This coin-
cided with the reports of several other animal mod-
els for the induction of pancreatic cancer (61). Some
of the most interesting experimental work has come
from the laboratory of Longnecker, who showed
that pancreatic carcinogenesis is enhanced in ani-
mals fed diets containing 20% corn oil (Table 14).
Additional data from Longnecker's laboratory
Table 11. Marginal lipotrope deficiency and
microsomal characteristics.a
Microsomal protein, mg/g
Cytochrome P-450, nmole/mg
protein
Ethylmorphine N-demethylase
nmole/mg protein
Control
24.4 + 1.5
1.8 + 0.1
Lipotrope-
deficient
18.7 1.1
0.5 + 0.1
787 79 572 ± 40
Table 13. Promoting effect of choline deficiency and partial he-
patectomy on spontaneous B.C3F, mouse hepatocarcinogenesis.
Tumors
Treatment after 9 mo., %
Control 0.0
Control + partial hepatectomy 20.0
Choline-deficient 100.0
Choline-deficient + partial hepatectomy 40.0
Data of Newberne, de Camargo and Clark (57).
nmole/100 g body weight x
104
Ethoxycoumarin O-dealkylase
nmole/mg protein
nmole/100 g body weight
Cytochrome c reductase
nmole/mg protein
nmole/100 g body weight x
102
aData of Campbell et al. (55)
6.0 4.6
0.350 + 0.09 0.215 + 0.03
26.8 17.3
66.2 + 3.7 52.4 ± 3.5
50.8 42.2
Table 14. Effect of dietary fat on pancreatic cancer in rats.
Pancreas Pancreatic
Treatment weight, g tumors
Control 1.4 ± 0.3 0.0
Control + azaserine 2.6 ± 1.4 71.0
Unsaturated fat + azaserine 4.7 ± 2.5 100.0
Saturated fat + azaserine 2.6 ± 0.8 75.0
aData of Roebuck et al. (62).
Table 12. Effects of dietary fat during and after exposure to a carcinogenic dose of AFB, on tumor incidence.a
Beef fat Corn oil Incidence
During After During After of liver
treatment treatment treatment treatment tumors after Incidence
with with with with 14 mo. of lung
AFB, AFB, AFB, AFBI No. °h metastases, %
+ + 0 0 32 53 25.0
0 + 0 0 28 51 21.0
0 0 + + 60 100 60.3
0 0 0 + 38 66 36.8
aData of Newberne et al. (56).
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have shown that rats fed a semipurified diet devel-
oped more pancreatic tumors than rats feed a com-
mercial laboratory chow. Furthermore, selected
feeding of these diets during the administration of
carcinogen and after the carcinogen had been dis-
continued seemed to indicate that the inhibitory ef-
fect of the chow diet on carcinogenesis was exerted
during the post-initiation phase (Table 15). In addi-
tion, the supplementation of the diet with retinyl
acetate during the post initiation phase also inhib-
ited the progression of the pancreatic tumors in-
duced by azaserine (Table 16). These studies then
seem to infer that the influence of dietary fat qual-
ity, and perhaps quantity, as well as vitamin A are
acting at the post initiation phase of tumorigenesis,
(63).
A number of other investigators have studied the
effects of diet on pancreatic tumors but there is lit-
tle information as to whether or not the diets act at
the initiation or at the post-initiation (promotion)
stages of tumor development (61, 64). The summa-
tion of available data indicate that diets high in un-
saturated fat enhance pancreatic carcinogenesis in
the rat animal model.
Colon Carcinogenesis
There have been numerous studies on the epi-
demiology of colon cancer in recent years, in partic-
ular, on how dietary factors may influence this type
of neoplasm (65-69). While some of these studies
Table 15. Effect of diet on postinitiation phase of azaserine-
induced pancreatic tumors.a
Diet/treatment Mean no.
Initiation Post-initiation Pancreas nodules/
phase phase weight, gb pancreasb
Control, semisynthetic Semisynthetic 1.3 ± 0.2 0.7 ± 0.9
Semisynthetic + AZA Semisynthetic 1.5 ± 0.2 16.7 ± 7.6
Chow + AZA Semisynthetic 1.4 ± 0.1 14.3 ± 11.7
aData of Longnecker et al. (63).
bMeans, 10 rats per group.
Table 16. Effect of diet on postinitiation phase of azaserine
carcinogenesis in rats.,'
Diet/treatment
Initiation Post-initiation
phase phase
Control, semisynthetic Semisynthetic
Semisynthetic + AZA Semisynthetic
Semisynthetic + AZA Chow
Semisynthetic + AZA Semisynthetic
+ retinyl
acetate
aData of Longnecker et al. (63).
Rats
with
pancreatic
Body tumors
weight, g No. %
745 ± 105 0/16 0
706 ± 83 10/18 56
578 ± 55 0/17 0
717 ± 77 3/30 30
suggest that diets high in fat and low in fiber may
be associated with increased incidence of large
bowel cancer in human populations, the data are not
so clearly defined. However, it is apparent that the
more economically developed societies have a
greater incidence of colon cancer with the highest
incidence rates found in North America, New Zea-
land and Western Europe. Intermediate rates are
found in Eastern Europe and the Balkans and the
lowest incidences are observed in Africa, Latin
America and Asia, (66, 70).
The evidence for environmental dietary factors
and colon cancer is particularly convincing from
studies of migrants from Japan and Poland to the
United States and Australia (71, 72). These studies
indicate that colon cancer rates are higher in the
first and second generation Japanese immigrants to
the United States and in Polish immigrants to Aus-
tralia than in native Japanese in Japan and in na-
tive Poles from Poland. The increasing westerniza-
tion of the Japanese diet coincides with the in-
creased development of colon cancer in the Japa-
nese.
In the United States, the incidence of colon can-
cer in Mormons is lower than in other U.S. popula-
tion groups with the exception of the Seventh Day
Adventists (73). Mormons consume more breads
made from whole grain and more vegetables and
fruits than their counterparts, who have a higher in-
cidence of colon cancer, (68). Furthermore, a number
of other studies have shown that those who con-
sume less meat and more vegetables have smaller
risk of colon cancer (74, 75).
A number of investigators have suggested that
dietary fat is closely correlated with the incidence
of colon cancer. While much of the data are inter-
esting and suggestive, even the experimental re-
sults in animal models require validation (65, 76, 77).
Others have suggested that the large bowel cancer
rates are closely correlated with the consumption of
meat and other animal proteins as well as total fat
(78). While some of the data are convincing on the
face of the evidence, other reports leave the matter
open to question; additional well designed epidemio-
logic and experimental animal studies are required.
The following few cases illustrate one view of the
current state ofknowledge.
Burkitt (79) was one of the first to suggest that
the low incidence of bowel cancer in most African
populations was associated with a high dietary fiber
intake. Conversely, low fiber diets consumed by
Western populations are associated with a high inci-
dence of colon cancer. Further evidence from a re-
cent study compares Finland and Denmark popula-
tions with New York populations. Some Finnish
populations are at low risk, whereas Danish and
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New York populations are at high risk; the indica-
tions from the study were that the low risk of colon
cancer in Finland was associated with high dietary
fiber intake (80, 81).
In addition to the fat and fiber concepts, other in-
vestigators have suggested that bile acid secretion
associated with fat content in the diet is related in
some way to colon cancer. That aspect will be cov-
ered in more detail by others at this conference. It
must be borne in mind, however, that this is an ex-
tremely complex area and that it is quite unlikely
that any one single dietary nutrient is going to have
a primary effect.
Experimental studies in animal models have
helped to clarify some aspects of dietary effects on
colon cancer. The model using dimethylhydrazine
(DMH-treated rats has been the most widely used,
and while there has been a suggestion that DMH
produces intestinal tumors by way of two-stage
mechanism (82), this is not yet firmly established.
If such a two-stage mechanism could be clearly
shown for colon carcinogenesis, it would make it
much simpler to separate the initiation stages from
the post initiation (promotion) stages of tumor de-
velopment. It is pointed out by some investigators
(83, 84) that, while these suggestions are provoca-
tive and interesting, the entire process appears to
be much too complex at this point to clearly sepa-
rate initiation from promotion. Among other fac-
tors, the necessity for multidose scheduling in order
to produce the tumors complicates separation into
distinct stages. However, separation of the initi-
ation from promotional stages should be a primary
goal of investigators.
Many investigators have studied the role of die-
tary fat in colon carcinogenesis as well as the effects
of fiber and other factors. At this point if there are
specific factors involved in promotion of colon can-
cer it seems to be associated more with dietary fat.
For example, Nigro et al. (85) compared tumors in
rats by administration of a chemical carcinogen and
observed that 35% fat had an enhancing effect com-
pared to lower fat levels.
In studies conducted in our laboratories diets
marginally deficient in lipotropes but high in fat ap-
pear to enhance DMH induced colon carcinogenesis
in rats (86). While these data suggest that the total
amount of dietary fat may play a role in the patho-
genesis of colon cancer it does not indicate the time-
span during carcinogenesis that the fat exerts its ef-
fect. Table 17 lists the results of studies, typical of
many other investigations that we have conducted
in our laboratory.
Typical also of other studies are those of Reddy
et al. (87) which indicated that animals fed 20% lard
or 20% corn oil were more susceptible to colon tu-
mor induction by DMH than those fed 5% of either
of these two fats. Further, Broitman et al. (88)
showed that rats fed a 25% safflower oil diet and
treated with DMH had more large bowel tumors
than animals fed either the 5% or 20% coconut oil
diets. These data indicate that diets rich in polyun-
saturated fats are more effective tumor promoters
than diets containing saturated fat at a comparable
level.
Recent studies by Bull et al. (89) have indicated
that the enhanced tumorigenesis in animals fed high
fat diets is due to promotional effects. The ingestion
of high fat diets increased the incidence of tumors
induced by azoxymethane if fed after azoxymethane
administration but not during or before treatment
with carcinogen. This indicates an example of prob
able tumor promotion by dietary fat and empha-
sizes further this encouraging area for research. It
is more significant since some characteristics in hu-
man tumors correspond well with those in a variety
ofanimal models (90).
Another dietary constituent that is in some way
related to enhancement of colon carcinogenesis is vi-
tamin A and the retinoids, (25, 50). In the case of the
retinoids, however, it appears that a deficiency en-
hances the induction of tumors. Using the colon car-
cinogen DMH we have clearly shown that tumor in-
duction is accelerated by vitamin A deficiency.
Another example, using a different type of carcino-
gen, illustrates the apparent enhancing effect of a
deficiency of vitamin A on colon carcinogenesis but
does not clearly point out the period during which
the effect is exerted in the aflatoxin B1 model where
not only liver but colon tumors are produced (Table
18). An interesting and perhaps significant observa-
tion is that in the vitamin A-deficient colon there is
a modification of microsomal enzyme activity and of
aflatoxin metabolism, and binding to cellular macro-
molecules of the colon epithelium (91). In this case,
the effects might be exerted either during exposure
to the carcinogen or following exposure, since re-
moval of the DNA adducts can continue over a long
period of time following exposure to the carcinogen.
Thus if the rate of removal or repair of DNA were
affected during the promotional stage, this could
have an influence directly on carcinogenesis.
Table 17. Dietary fat and rat colon tumors.a
Rats with No. of
Dimethylhydrazine colon tumors/tumor-
Diet dose, mg/kg carcinoma, % bearing rat
Control 300 86 2.0
High-fat 300 100 3.7
Control 150 56 1.1
High-fat 150 85 2.6
aTumors were induced by dimethylhydrazine.
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Table 18. Enhancement of AFB, colon carcinogenesis by
Vitamin A deficiency.a
Vitamin A Tumor incidence, %
intake Sex Colon Liver
Adequate M 0 48
Deficient M 12 22
Excessive M 0 38
Adequate M 4 88
F 8 79
Deficient M 29 89
F 28 76
Excessive M 8 92
F 10 84
aData of Newberne and Rogers (50).
Discussion and Conclusions
As pointed out earlier in this presentation, there
are a number of chemicals recognized as initiators
and many others that are recognized as promoters
of the carcinogenic process. It is quite important
that we understand not only the mechanisms of
initiation of carcinogenesis but the later events that
occur in the putative promotional stage. A good
example of the complexity of the carcinogenic
process is exhibited by benzo(a)pyrene. When an
animal is exposed to this chemical there is no im-
mediate induction of neoplasia. Generally, there is a
lag of several months, and then a stepwise change
in the properties of cells occurs which usually in-
cludes hyperplasia, followed by a benign tumor and
later, a fully malignant one. It is the latter steps,
from a clinical point of view, which are the most im-
portant and troublesome because if they did not oc-
cur as has been repeatedly shown, benign tumors
could be removed and the disease could be cured. It
appears that early stages of a number of target or-
gan cancers may be reversible or they can regress.
The latter stages are much less readily reversed
and it is the later stages which provide the greatest
challenge to investigators.
Using benzo(a)pyrene as an example, it is gener-
ally accepted that the first step in benzo(a)pyrene
carcinogenesis is the covalent binding of the carcino-
gen to the nucleic acids in the cells. Before this
binding can occur, the carcinogen must be activated,
in this case, to a dihydrodiolepoxide which in turn
links by way of the number 10 position to the 2-
amino of guanine. Thus the metabolism of the
compound and factors that influence this can be of
major importance to appearance of cancer (3). It is
during this period that dietary factors may act.
In our attempts to learn more about promotion
specifically, the surface has only been scratched; we
know very little about nutrients which affect pro-
motion and virtually nothing about the mechanisms
whereby this is achieved. In one sense, considering
the effects of vitamin A, it would appear that differ-
entiation is the key to the whole process. Since it
appears that vitamin A and the retinoids act during
the promotional stage, differentiation must be the
key event that prevents the formation of malignant
tumors. However to produce a cancer cell, the pre-
vious pattern of gene expression of that cell must
be reprogrammed. Perhaps it is during this period
that some of the dietary effects are exerted. To con-
vert a cell from one that is normally differentiated
it must be diverted from the usual mode of terminal
differentiation and converted to one of exponential
division that proceeds into the carcinogenic process,
eventuating in cancer. These aspects we know very
little about even in the well defined mouse skin two-
stage carcinogenic process.
The most we can say at this point about nutrients
and promotion of intestinal tumors is that there
does appear to be some relationship between pro-
moters and gastrointestinal cancer. It appears also,
at this point, that it is premature to attempt to as-
sign specific carcinogens to stages of initiation or
promotion; the process is probably much more com-
plex. Furthermore, it seems illogical to assume that
nutrients act only during one period of tumor induc-
tion. Since, under some circumstances, initiators are
mutagenic and promoters are not, definitions should
be worked out to encompass the more complex
areas related to tumor initiation and promotion, par-
ticularly with diet and nutrition.
In terms of gastrointestinal cancer we can say
that dietary ingredients do affect cancer of the
esophagus, the stomach, the pancreas, the liver and
the colon. However, in most cases it is not clear as
to whether it is during the initiation period or the
promotional stage that these ingredients are exert-
ing their effects. This area of research has some sig-
nificant and far-reaching implications in attempts to
prevent cancer.
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